Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

Recruiting

• Conditions: Coronary Artery Disease

• Registration Number: NCT01788592
• Lead Sponsor: Seung-Jung Park

Brief Summary

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-01
• Study First Submitted: 2013-02-08
• Study First Submitted QC: 2013-02-08
• Study First Posted: 2013-02-11
• Status Verified: 2023-06
• Last Update Submitted: 2023-06-27
• Last Update Posted: 2023-06-28
• Primary Completion: 2030-10
• Study Completion: 2030-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 50000

Inclusion Criteria

• coronary disease amenable to percutaneous coronary intervention (PCI)
• no clinical and lesion limitations

Exclusion Criteria

• patients with a mixture of several drug eluting stents
• terminal illness with life expectancy less than 1 year
• patients with cardiogenic shock

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major Adverse Cardiac Event	1year	Death from any causes, myocardial infarction or any repeat revascularization

Secondary Outcome Measures

Name	Time	Method
Stent thrombosis by Academic Research Consortium criteria	1year
Myocardial Infarction	1year
Target vessel revascularization	1year
all cause Death	1year
Target lesion revascularization	1year
Any repeat revascularization	1year
The composite of Death or myocardial infarction	1year
New lesion revascularization	1year

Trial Locations

Locations (1)

Asan Medical Center; 🇰🇷 Seoul, Korea, Republic of